Committee for Orphan Medicinal Products (COMP) meeting report on the review of applications for orphan designation May 2019

28 mai 2019

BlueReg

The COMP adopted 12 positive opinions recommending medicines for designation as orphan medicinal products to the European Commission.

BlueReg

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus